Jelena S. Bila

Belgrade, SE, Serbia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 50 publications

Correction: Multiple myeloma in the real world settings: prognostic significance of 1q21 chromosomal abnormalities - single center experience.

Correction: Multiple myeloma in the real world settings: prognostic significance of 1q21 chromosomal abnormalities - single center experience.

Journal: Frontiers in oncology

Published: June 26, 2026

Circulating Tumor DNA in Multiple Myeloma: Current Insights and Future Perspectives.

Circulating Tumor DNA in Multiple Myeloma: Current Insights and Future Perspectives.

Journal: Biology

Published: May 25, 2026

Multiple myeloma in the real-world practice: clinical and prognostic indeces - single center experience.

Multiple myeloma in the real-world practice: clinical and prognostic indeces - single center experience.

Journal: Frontiers in oncology

Published: April 29, 2026

Multiple myeloma in the real world settings: prognostic significance of 1q21 chromosomal abnormalities - single center experience.

Multiple myeloma in the real world settings: prognostic significance of 1q21 chromosomal abnormalities - single center experience.

Journal: Frontiers in oncology

Published: December 10, 2025

Real-World Data of Light Chain (AL) Amyloidosis: Prognostic Indices and Treatment Patterns.

Real-World Data of Light Chain (AL) Amyloidosis: Prognostic Indices and Treatment Patterns.

Journal: Biomedicines

Published: September 24, 2025

Sequencing BCMA- and GPRC5D-targeting immunotherapies in multiple myeloma: Practical guidance from the European Myeloma Network.

Sequencing BCMA- and GPRC5D-targeting immunotherapies in multiple myeloma: Practical guidance from the European Myeloma Network.

Journal: HemaSphere

Published: September 01, 2025

EHA-EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma.

EHA-EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma.

Journal: Nature reviews. Clinical oncology

Published: June 05, 2025

High NK cell counts at day 90 predict improved survival in event-free patients after T-cell depleted allogeneic stem cell transplantation.

High NK cell counts at day 90 predict improved survival in event-free patients after T-cell depleted allogeneic stem cell transplantation.

Journal: Frontiers in immunology

Published: February 16, 2025

Disease Characteristics and Treatment Outcomes of Myeloma Patients Under 50 Years of Age: An Analysis of the Balkan Myeloma Study Group.

Disease Characteristics and Treatment Outcomes of Myeloma Patients Under 50 Years of Age: An Analysis of the Balkan Myeloma Study Group.

Journal: Clinical lymphoma, myeloma & leukemia

Published: November 18, 2024

Risk Factors for Venous Thromboembolism in Acute Promyelocytic Leukemia.

Risk Factors for Venous Thromboembolism in Acute Promyelocytic Leukemia.

Journal: Cancers

Published: November 04, 2024

Managing novel therapies and concomitant medications in chronic lymphocytic leukemia: key challenges.

Managing novel therapies and concomitant medications in chronic lymphocytic leukemia: key challenges.

Journal: Frontiers in pharmacology

Published: October 27, 2024

Validation of the second revision of the international staging system (R2-ISS) for overall survival in multiple myeloma in a real-world cohort: an analysis by the Balkan myeloma study group (BMSG).

Validation of the second revision of the international staging system (R2-ISS) for overall survival in multiple myeloma in a real-world cohort: an analysis by the Balkan myeloma study group (BMSG).

Journal: Leukemia & lymphoma

Published: August 14, 2024

Showing 1-12 of 50

Last Updated: 09/26/2026